News Feed
Case Report: A novel hemizygous nonsense variant in PPP1R3F gene associated with developmental delay, intellectual disability and autism spectrum disorder
BackgroundPPP1R3F deficiency syndrome is an extremely rare, recently identified X-linked recessive neurodevelopmental disorder. It is caused by hemizygous variants in the PPP1R3F gene, which encodes a glycogen-targeting subunit of the brain-specific protein phosphatase 1…
News
3107 results
How the Pope’s Magnifica Humanitas offers a template for individuals to meet the AI moment
Pope Leo XIV’s new encyclical on artificial intelligence includes a statement that warrants serious attention from technologists and policymakers: “Technology is never neutral.” Magnifica Humanitas (“Magnificent Humanity”) is a clarion call to all people to act with courage and solidarity…
STAT+: The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD: A Signal Characterisation Pilot Study
Conditions: Post-Traumatic Stress Disorder Interventions: Device: Continuous wearable physiological monitoring (EmbracePlus, Empatica); Drug: Ketamine-assisted therapy (independently arranged); Other: Structured pre- and post-session interviews Sponsors: Adriaan Dirk van der Wart Not yet recruiting
Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD
Conditions: Attention Deficit Disorder With or Without Hyperactivity (ADHD) Interventions: Other: Group Therapy for Improving Emotional Acceptance and Regulatory Skills in Adults with ADHD (GEARS) Sponsors: Karolinska Institutet Recruiting
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
Conditions: Schizophrenia; Schizo Affective Disorder; Healthy Interventions: Drug: Placebo; Drug: IL-23 Sponsors: University of Maryland, Baltimore Not yet recruiting
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Conditions: Schizophrenia Interventions: Drug: Aticaprant; Drug: Placebo Sponsors: Janssen Research & Development, LLC Recruiting
Pilot Feasibility Study With Doulas
Conditions: Post Partum; Maternal Depression; Maternal Depression and Parent Practices, Postpartum Interventions: Behavioral: YouMatter Sponsors: Duke University Not yet recruiting
The Download: climate tech goes public and the AI Hype Index returns
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Climate tech companies are going public. What’s next? Solar and battery company Solv Energy went public…
Gut microbiome screens could identify risk of Parkinson’s disease years before symptoms appear
Nature Medicine, Published online: 28 May 2026; doi:10.1038/s41591-026-04458-8Innovative microbiome analysis revealed a part of the gut microbiome that changes coherently from healthy individuals across those with genetic risk of Parkinson’s disease to patients who are symptomatic. A large range of…
BrainBaseline Assessment of Cognition and Everyday Functioning (“BRACE”-ing for the Future): Establishing iPad-Based Norms for Cognitive Function in the Multicenter AIDS Cohort Study and Women’s Interagency HIV Study Combined Cohort Study
Background: Digital cognitive assessments are increasingly used in large-scale studies to assess brain health, offering scalable, standardized, and self-directed testing solutions. Cognitive function remains a concern for people with HIV despite antiretroviral therapy. The BRACE (BrainBaseline Assessment of Cognition and…
Negative Online Experiences Are Common but Often Go Unreported Among Youth With Mental Health and Neurodevelopmental Concern
New Child Mind Institute study finds more than one in four youth experienced a negative online experience in the past year, yet only one in five reported the incident through platform tools. The post Negative Online Experiences Are Common but…
JAACAP Open: Negative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
Growing engagement with digital spaces among children and adolescents increases the risk of negative online experiences (NOE). This study examined the prevalence, risk factors, and reporting barriers for NOE among youth with mental health and neurodevelopmental conditions. The post JAACAP…
Recruitment and Participation of Black Home Health Care Patients in Speech-Based Cognitive Research: Mixed Methods Feasibility Study
Background: Older Black adults remain underrepresented in dementia research, particularly in studies using speech-based methods for early cognitive assessment. Understanding how to effectively recruit and engage this population in research involving audio-recorded interactions is critical to ensuring equitable inclusion and…
STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress
The U.S. is taking extraordinary steps to keep Ebola out. But its policies may create risks for Americans infected overseas and discourage volunteers from responding to the outbreak.
STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, from regulators, to investors, and even public…
Biotech exec Jeremy Levin on the industry’s strategic turning point
This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.
How a new extraction process could unlock the world’s lithium
Researchers say they’ve found a new way to extract lithium, a crucial metal used in the lithium-ion batteries that power electric vehicles and energy storage arrays. This new technique could be more environmentally friendly and cheaper than existing ones. The…
STAT+: Trump’s pharma deals get tested
We still have a lot of questions about Trump's MFN deals with pharma companies.
News Feed
Case Report: A novel hemizygous nonsense variant in PPP1R3F gene associated with developmental delay, intellectual disability and autism spectrum disorder
BackgroundPPP1R3F deficiency syndrome is an extremely rare, recently identified X-linked recessive neurodevelopmental disorder. It is caused by hemizygous variants in the PPP1R3F gene, which encodes a glycogen-targeting subunit of the brain-specific protein phosphatase 1…
News
3107 results
How the Pope’s Magnifica Humanitas offers a template for individuals to meet the AI moment
Pope Leo XIV’s new encyclical on artificial intelligence includes a statement that warrants serious attention from technologists and policymakers: “Technology is never neutral.” Magnifica Humanitas (“Magnificent Humanity”) is a clarion call to all people to act with courage and solidarity…
STAT+: The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD: A Signal Characterisation Pilot Study
Conditions: Post-Traumatic Stress Disorder Interventions: Device: Continuous wearable physiological monitoring (EmbracePlus, Empatica); Drug: Ketamine-assisted therapy (independently arranged); Other: Structured pre- and post-session interviews Sponsors: Adriaan Dirk van der Wart Not yet recruiting
Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD
Conditions: Attention Deficit Disorder With or Without Hyperactivity (ADHD) Interventions: Other: Group Therapy for Improving Emotional Acceptance and Regulatory Skills in Adults with ADHD (GEARS) Sponsors: Karolinska Institutet Recruiting
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
Conditions: Schizophrenia; Schizo Affective Disorder; Healthy Interventions: Drug: Placebo; Drug: IL-23 Sponsors: University of Maryland, Baltimore Not yet recruiting
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Conditions: Schizophrenia Interventions: Drug: Aticaprant; Drug: Placebo Sponsors: Janssen Research & Development, LLC Recruiting
Pilot Feasibility Study With Doulas
Conditions: Post Partum; Maternal Depression; Maternal Depression and Parent Practices, Postpartum Interventions: Behavioral: YouMatter Sponsors: Duke University Not yet recruiting
The Download: climate tech goes public and the AI Hype Index returns
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Climate tech companies are going public. What’s next? Solar and battery company Solv Energy went public…
Gut microbiome screens could identify risk of Parkinson’s disease years before symptoms appear
Nature Medicine, Published online: 28 May 2026; doi:10.1038/s41591-026-04458-8Innovative microbiome analysis revealed a part of the gut microbiome that changes coherently from healthy individuals across those with genetic risk of Parkinson’s disease to patients who are symptomatic. A large range of…
BrainBaseline Assessment of Cognition and Everyday Functioning (“BRACE”-ing for the Future): Establishing iPad-Based Norms for Cognitive Function in the Multicenter AIDS Cohort Study and Women’s Interagency HIV Study Combined Cohort Study
Background: Digital cognitive assessments are increasingly used in large-scale studies to assess brain health, offering scalable, standardized, and self-directed testing solutions. Cognitive function remains a concern for people with HIV despite antiretroviral therapy. The BRACE (BrainBaseline Assessment of Cognition and…
Negative Online Experiences Are Common but Often Go Unreported Among Youth With Mental Health and Neurodevelopmental Concern
New Child Mind Institute study finds more than one in four youth experienced a negative online experience in the past year, yet only one in five reported the incident through platform tools. The post Negative Online Experiences Are Common but…
JAACAP Open: Negative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
Growing engagement with digital spaces among children and adolescents increases the risk of negative online experiences (NOE). This study examined the prevalence, risk factors, and reporting barriers for NOE among youth with mental health and neurodevelopmental conditions. The post JAACAP…
Recruitment and Participation of Black Home Health Care Patients in Speech-Based Cognitive Research: Mixed Methods Feasibility Study
Background: Older Black adults remain underrepresented in dementia research, particularly in studies using speech-based methods for early cognitive assessment. Understanding how to effectively recruit and engage this population in research involving audio-recorded interactions is critical to ensuring equitable inclusion and…
STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress
The U.S. is taking extraordinary steps to keep Ebola out. But its policies may create risks for Americans infected overseas and discourage volunteers from responding to the outbreak.
STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, from regulators, to investors, and even public…
Biotech exec Jeremy Levin on the industry’s strategic turning point
This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.
How a new extraction process could unlock the world’s lithium
Researchers say they’ve found a new way to extract lithium, a crucial metal used in the lithium-ion batteries that power electric vehicles and energy storage arrays. This new technique could be more environmentally friendly and cheaper than existing ones. The…
STAT+: Trump’s pharma deals get tested
We still have a lot of questions about Trump's MFN deals with pharma companies.